Severe Fontan‐Associated Liver Disease and Its Association With Mortality
Journal of the American Heart Association · 03.10.2023 · 12 (19)
DOI: 10.1161/jaha.121.024034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.10.2023. Verfasst von Carlos-Eduardo Guerrero-Chalela und 5 weiteren Autor:innen. Beteiligte Einrichtung: McGill Adult Unit for Congenital Heart Disease Excellence (MAUDE Unit) McGill University Health Centre Montreal Quebec Canada. Hauptthemen laut MEDLINE: Liver Diseases, Heart Defects, Congenital, Heart Septal Defects, Ventricular, Fontan Procedure. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Data are rare about the incidence of severe Fontan‐associated liver disease (FALD) and its association with mortality. We sought to: (1) estimate the probability of developing severe FALD in patients who undergo the Fontan procedure (Fontan patients), compared with severe liver complications in patients with a ventricular septal defect; (2) assess the severe FALD‐mortality association; and (3) identify risk factors for developing severe FALD. Methods and Results Using the Quebec Congenital Heart Disease database, a total of 512 Fontan patients and 10 232 patients with a ventricular septal defect were identified. Kaplan‐Meier curves demonstrated significantly higher cumulative risk of severe FALD in Fontan patients (11.95% and 52.24% at 10 and 35 years, respectively), than the risk of severe liver complications in patients with a ventricular septal defect (0.50% and 2.75%, respectively). At 5 years, the cumulative risk of death was 12.60% in patients with severe FALD versus 3.70% in Fontan patients without FALD (log‐rank P =0.0171). Cox proportional hazard models identified significant associations between the development of severe FALD and congestive heart failure and supraventricular tachycardia, with hazard ratios (HRs) of 2.36 (95% CI, 1.38–4.02) and 2.45 (95% CI, 1.37–4.39), respectively. More recent Fontan completion was related to reduced risks of severe FALD, with an HR of 0.95 (95% CI, 0.93–0.97) for each more recent year.
Conclusions
This large‐scale population‐based study documents that severe FALD in Fontan patients was associated with a >3‐fold increase in mortality. The risk of FALD is time‐dependent and can reach >50% by 35 years after the Fontan operation. Conditions promoting poor Fontan hemodynamics were associated with severe FALD development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- McGill Adult Unit for Congenital Heart Disease Excellence (MAUDE Unit) McGill University Health Centre Montreal Quebec Canada.
- Beth Raby Adult Congenital Heart Disease Clinic, Jewish General Hospital Montreal Quebec Canada.
- Fundacion Cardioinfantil-Instituto de Cardiologia Bogota Colombia.
ORCID-Profile: Carlos-Eduardo Guerrero-Chalela, Liming Guo, Ariane Marelli
Zitieren
APA
Guerrero-Chalela, C. E., Therrien, J., Grossman, Y., Guo, L., Liu, A., & Marelli, A. (2023). Severe Fontan‐Associated Liver Disease and Its Association With Mortality. Journal of the American Heart Association, 12(19). https://doi.org/10.1161/jaha.121.024034
Vancouver
Guerrero-Chalela CE, Therrien J, Grossman Y, Guo L, Liu A, Marelli A. Severe Fontan‐Associated Liver Disease and Its Association With Mortality. Journal of the American Heart Association. 2023;12(19). doi:10.1161/jaha.121.024034
BibTeX
@article{GuerreroChalela2023,
author = {Guerrero-Chalela, Carlos-Eduardo and Therrien, Judith and Grossman, Yoni and Guo, Liming and Liu, Aihua and Marelli, Ariane},
title = {Severe Fontan‐Associated Liver Disease and Its Association With Mortality},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {19},
doi = {10.1161/jaha.121.024034}
}
EUVIMED